#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mitochondrial encephalomyopathy Glycogen storage disease type I Retinitis pigmentosa Epstein-Barr virus infection Hepatitis D Gastrointestinal stromal tumour Plasma cell myeloma recurrent Pyruvate kinase deficiency anaemia Arteriovenous malformation Anti-myelin-associated glycoprotein associated polyneuropathy Acute myeloid leukaemia refractory Heart disease congenital Hyperinsulinaemic hypoglycaemia Neurodegenerative disorder Intracranial calcification More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Basic Information Glycogen storage disease type V – Trials in Disease Glycogen storage disease type I – Life with Disease Breast angiosarcoma metastatic – Basic Information Hereditary ataxia – Diagnostics Mitochondrial myopathy Pleomorphic leiomyosarcoma – Trials in Disease Usher’s syndrome – Treatment Haemophilia Primary biliary cholangitis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pasireotide Diaspartate Azd7798 Trandolapril Olmesartan Medoxomil Hst-1011 Azd9550 Rbd5044 Sodium Etrasimod Arginine Immunoglobulin G Lixudebart ANX007 Diclofenac Epolamine Vesleteplirsen Tisagenlecleucel Almagate Cemdisiran Avacincaptad Pegol Ganciclovir Iron Sucrose Cedazuridine More therapies…

    Learn about Your Condition

    Amyloidosis Uveal melanoma Optic atrophy Circulatory collapse Neuralgia Benign renal neoplasm Haematological infection Chronic coronary syndrome Lymphangioleiomyomatosis Cervix carcinoma stage II Embolism venous Allergic respiratory disease Spinal cord injury Congenital myopathy Anal incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Relapsing-remitting multiple sclerosis

  • Study on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Diroximel Fumarate
    • Glatiramer Acetate
    • Interferon Beta-1A
    France

  • Study Comparing the Effects of Ozanimod and Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Fingolimod
    • Ozanimod Hydrochloride
    Italy Poland Portugal Romania Spain

  • Study on the Effects of Ozanimod on Inflammation in Patients with Relapsing Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Progressive relapsing multiple sclerosis
    • Multiple sclerosis
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Ozanimod
    Italy

  • Study on the Effects of IMU-838 (Vidofludimus Calcium) for Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    2 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Vidofludimus Calcium
    Bulgaria Germany Poland Romania

  • Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous Ocrelizumab in Children and Adolescents with Relapsing‑Remitting Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ocrelizumab
    France Germany Poland

  • Study of Lactobacillales and Lacidofil in Multiple Sclerosis Patients: Comparing Effectiveness of Probiotic Therapy

    Not yet recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Lactobacillus Rhamnosus, Strain Lcr35, Live
    • Ozanimod
    • Ofatumumab
    Poland
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!